PMID- 37026902 OWN - NLM STAT- MEDLINE DCOM- 20230411 LR - 20230508 IS - 1536-5964 (Electronic) IS - 0025-7974 (Print) IS - 0025-7974 (Linking) VI - 102 IP - 14 DP - 2023 Apr 7 TI - Role and mechanism of actin-related protein 2/3 complex signaling in cancer invasion and metastasis: A review. PG - e33158 LID - 10.1097/MD.0000000000033158 [doi] LID - e33158 AB - The actin 2/3 complex (Arp2/3) regulates actin polymerization and nucleation of actin filaments, is associated with cell motility, and has been shown to play a key role in the invasion and migration of cancer cells. nucleation-promoting factor (NPF) such as N-WASP (neural-WASP famly verprolin-homologous protein family), WAVE (WASP famly verprolin-homologous protein family), and WASH (WASP and Scar homologue) undergo conformational changes upon receipt of multiple upstream signals including Rho family GTPases, cdc42 (Cell division control protein 42 homolog), and phosphatidylinositol 4,5-bisphosphate (PtdIns 4,5 P2) to bind and activate the Arp2/3 complex. Once activated, the Arp2/3 complex forms actin-based membrane protrusions necessary for cancer cells to acquire an invasive phenotype. Therefore, how to influence the invasion and migration of cancer cells by regulating the activity of the Arp2/3 complex has attracted great research interest in recent years. Several studies have explored the effects of phosphorylation modifications of cortactin and several NPFs (Nucleation Promoting Factor) including N-WASP and WAVE on the activity of the Arp2/3 complex and ultimately on cancer cell invasiveness, and have attempted to suggest new strategies for antiinvasive therapy as a result. Other studies have highlighted the potential of targeting genes encoding partial or complete proteins of the Arp2/3 complex as a therapeutic strategy to prevent cancer cell invasion and metastasis. This article reviews the role of the Arp2/3 complex in the development, invasion, and metastasis of different types of cancer and the mechanisms regulating the activity of the Arp2/3 complex. CI - Copyright (c) 2023 the Author(s). Published by Wolters Kluwer Health, Inc. FAU - Zheng, Sihan AU - Zheng S AD - Department of Otorhinolaryngology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. FAU - Qin, Fengfeng AU - Qin F AD - Department of Otorhinolaryngology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. FAU - Yin, Ji AU - Yin J AD - Department of Otorhinolaryngology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. FAU - Li, Daiying AU - Li D AD - Department of Otorhinolaryngology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. FAU - Huang, Yanlin AU - Huang Y AD - Department of Otorhinolaryngology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. FAU - Hu, Lanxin AU - Hu L AD - Department of Otorhinolaryngology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. FAU - He, Lu AU - He L AD - Department of Otorhinolaryngology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. FAU - Lv, Caifeng AU - Lv C AD - Department of Otorhinolaryngology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. FAU - Li, Xiaohui AU - Li X AD - Department of Otorhinolaryngology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. FAU - Li, Sen AU - Li S AD - Spinal Surgery Department, the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. FAU - Hu, Wenjian AU - Hu W AUID- ORCID: 0000-0002-0580-4732 AD - Department of Otorhinolaryngology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. LA - eng PT - Journal Article PT - Review PL - United States TA - Medicine (Baltimore) JT - Medicine JID - 2985248R RN - 0 (Actin-Related Protein 2-3 Complex) RN - 0 (Actins) RN - 0 (Actin-Related Protein 2) RN - 0 (Actin-Related Protein 3) RN - 0 (Wiskott-Aldrich Syndrome Protein Family) SB - IM MH - *Actin-Related Protein 2-3 Complex/metabolism MH - Actins/metabolism MH - Actin-Related Protein 2 MH - Actin-Related Protein 3 MH - Wiskott-Aldrich Syndrome Protein Family/metabolism MH - *Neoplasms PMC - PMC10082322 COIS- The authors have no funding and conflicts of interest to disclose. EDAT- 2023/04/08 06:00 MHDA- 2023/04/11 06:42 PMCR- 2022/04/07 CRDT- 2023/04/07 10:12 PHST- 2023/04/11 06:42 [medline] PHST- 2023/04/07 10:12 [entrez] PHST- 2023/04/08 06:00 [pubmed] PHST- 2022/04/07 00:00 [pmc-release] AID - 00005792-202304070-00003 [pii] AID - 10.1097/MD.0000000000033158 [doi] PST - ppublish SO - Medicine (Baltimore). 2023 Apr 7;102(14):e33158. doi: 10.1097/MD.0000000000033158.